245 related articles for article (PubMed ID: 6608922)
1. Two-dimensional gel analysis demonstrates no structural alteration of HLA-B27 polypeptides between patients with ankylosing spondylitis and healthy individuals.
Trapani JA; Walker ID; McKenzie IF
Ann Rheum Dis; 1984 Apr; 43(2):177-80. PubMed ID: 6608922
[TBL] [Abstract][Full Text] [Related]
2. Structural identity of human histocompatibility leukocyte antigen-B27 molecules from patients with ankylosing spondylitis and normal individuals.
Karr RW; Hahn Y; Schwartz BD
J Clin Invest; 1982 Feb; 69(2):443-50. PubMed ID: 7056855
[TBL] [Abstract][Full Text] [Related]
3. Biochemical studies on a factor isolated from Klebsiella K43-BTS1 that cross-reacts with cells from HLA-B27 positive patients with ankylosing spondylitis.
Upfold LI; Sullivan JS; Geczy AF
Hum Immunol; 1986 Nov; 17(3):224-38. PubMed ID: 3539895
[TBL] [Abstract][Full Text] [Related]
4. Ankylosing spondylitis without B27: no evidence for gene conversion.
Pease CT; Ellis SA; McMichael AJ; Brewerton DA
Ann Rheum Dis; 1988 Dec; 47(12):1001-3. PubMed ID: 3264696
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical variants of HLA-B27.
Kaneoka H; Engleman EG; Grumet FC
J Immunol; 1983 Mar; 130(3):1288-92. PubMed ID: 6600481
[TBL] [Abstract][Full Text] [Related]
6. Klebsiella 'modifying factor': binding studies with HLA-B27+ and B27- lymphocytes.
Trapani JA; McKenzie IF
Ann Rheum Dis; 1985 Mar; 44(3):169-75. PubMed ID: 2579614
[TBL] [Abstract][Full Text] [Related]
7. Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls.
Calin A; Marder A; Becks E; Burns T
Arthritis Rheum; 1983 Dec; 26(12):1460-4. PubMed ID: 6606431
[TBL] [Abstract][Full Text] [Related]
8. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis.
Georgopoulos K; Dick WC; Goodacre JA; Pain RH
Clin Exp Immunol; 1985 Dec; 62(3):662-71. PubMed ID: 3878755
[TBL] [Abstract][Full Text] [Related]
9. Measurement of HLA class I expression in ankylosing spondylitis.
Creamer P; Edmonds J; Sullivan J; Matthews S
Ann Rheum Dis; 1992 Oct; 51(10):1138-42. PubMed ID: 1444627
[TBL] [Abstract][Full Text] [Related]
10. HLA-B27-restricted T cells from patients with ankylosing spondylitis recognize peptides from B*2705 that are similar to bacteria-derived peptides.
Frauendorf E; von Goessel H; May E; Märker-Hermann E
Clin Exp Immunol; 2003 Nov; 134(2):351-9. PubMed ID: 14616798
[TBL] [Abstract][Full Text] [Related]
11. Expression of HLA-B27 antigens on mononuclear leucocytes in ankylosing spondylitis.
van der Gaag R; Luyendijk L; Linssen A; Kijlstra A
Clin Exp Immunol; 1985 May; 60(2):311-5. PubMed ID: 3874023
[TBL] [Abstract][Full Text] [Related]
12. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
Sullivan JS; Geczy AF
Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
[TBL] [Abstract][Full Text] [Related]
13. HLA-B27-derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis.
Märker-Hermann E; Meyer zum Büschenfelde KH; Wildner G
Arthritis Rheum; 1997 Nov; 40(11):2047-54. PubMed ID: 9365095
[TBL] [Abstract][Full Text] [Related]
14. HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis.
McGuigan LE; Geczy AF; Prendergast JK; Edmonds JP; Hart HH; Bashir HV
Ann Rheum Dis; 1986 Feb; 45(2):144-8. PubMed ID: 3484937
[TBL] [Abstract][Full Text] [Related]
15. Ankylosing spondylitis, HLA-B27, and Klebsiella: a study of lymphocyte reactivity of anti-Klebsiella sera.
Singh B; Milton JD; Woodrow JC
Ann Rheum Dis; 1986 Mar; 45(3):190-7. PubMed ID: 3485408
[TBL] [Abstract][Full Text] [Related]
16. Acute anterior uveitis, ankylosing spondylitis, back pain, and HLA-B27.
Beckingsale AB; Davies J; Gibson JM; Rosenthal AR
Br J Ophthalmol; 1984 Oct; 68(10):741-5. PubMed ID: 6236842
[TBL] [Abstract][Full Text] [Related]
17. A factor shed by lymphoblastoid cell lines of HLA-B27 positive patients with ankylosing spondylitis, specifically modifies the cells of HLA-B27 positive normal individuals.
Orban P; Sullivan JS; Geczy AF; Upfold LI; Coulits N; Bashir HV
Clin Exp Immunol; 1983 Jul; 53(1):10-6. PubMed ID: 6191893
[TBL] [Abstract][Full Text] [Related]
18. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease.
Cauli A; Dessole G; Fiorillo MT; Vacca A; Mameli A; Bitti P; Passiu G; Sorrentino R; Mathieu A
Rheumatology (Oxford); 2002 Dec; 41(12):1375-9. PubMed ID: 12468816
[TBL] [Abstract][Full Text] [Related]
19. IgG antibodies to enterobacteria 60 kDa heat shock proteins in the sera of HLA-B27 positive ankylosing spondylitis patients.
Dominguez-López ML; Burgos-Vargas R; Galicia-Serrano H; Bonilla-Sánchez MT; Rangel-Acosta HH; Cancino-Diaz ME; Jiménez-Zamudio L; Granados J; García-Latorre E
Scand J Rheumatol; 2002; 31(5):260-5. PubMed ID: 12455814
[TBL] [Abstract][Full Text] [Related]
20. HLA-B27 in possible ankylosing spondylitis with peripheral arthritis.
Zeidler H; Wagener P; Eckert G; Freyschmidt J; Fritsch R; Creutzig H; Deicher H
Rheumatol Int; 1982; 2(1):35-40. PubMed ID: 6983709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
